Professor David Cooper
Director, The Kirby Institute, University of New South Wales
David Cooper AO, Scientia Professor of Medicine at the University of New South Wales, a Fellow of the Australian Academy of Science (FAA) and a Fellow of the Australian Academy of Health and Medical Sciences (FAAHMS), is Director of the Kirby Institute for infection and immunity in society, Sydney, Australia. The Kirby Institute is funded by the Australian Government to conduct research into the HIV/AIDS epidemic in Australia, with the ultimate aim of reducing the burden of the HIV/AIDS epidemic for the affected community. Kirby Institute work also includes extensive research into viral hepatitis, HIV biomedical prevention studies, laboratory-based research, sexual health, indigenous health, and numerous international collaborations. Professor Cooper’s previous positions include President of the International AIDS Society (IAS) and Chairman of the World Health Organisation-UNAIDS HIV Vaccine Advisory Committee (VAC). He is a former Director of HIV-NAT, a clinical research and trials collaboration based at the Thai Red Cross AIDS Research Centre at the Chulalongkorn University Hospital in Bangkok, Thailand. Currently, he is leading several large international clinical trials and cohorts to optimise antiretroviral therapy (ART) in low and middle-income countries. He has been author or co-author on more than 800 peer-reviewed publications, has served on the editorial boards of many journals, and maintains a clinical practice at St Vincent’s Hospital, Sydney.